Key statistics dashboard for Cabaletta Bio, Inc. (CABA). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Cabaletta Bio, Inc. is a biotechnology firm in the clinical development stage, specializing in the invention and advancement of sophisticated engineered T cell therapies. Its core mission is to treat autoimmune diseases where B cells are implicated in producing harmful autoantibodies. The company's unique chimeric autoantibody receptor (CAAR) T cell platform is engineered to precisely target and eradicate these specific disease-causing B cells.
Stock Data
| Price | $2.49 |
| Market Cap | $406M |
| Enterprise Value | $206.6M |
| Beta | 3.29 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -1.64 |
| Price / Book | 1.86 |
| P/S | 0.00 |
| EV/EBITDA | -1.17 |
| EV/Sales | 0.00 |
| EV/FCF | -1.34 |
| P/FCF | -2.74 |
| Earnings Yield | -48.17% |
| FCF Yield | -37.98% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 0.00% |
| EBIT Margin | 0.00% |
| EBITDA Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | -128.27% |
| Return on Assets | -70.63% |
| Return on Invested Capital | -78.51% |
| Return on Capital Employed | -85.56% |
Financial Health
| Current Ratio | 5.79 |
| Quick Ratio | 5.79 |
| Cash Ratio | 5.64 |
| Debt / Equity | 0.12 |
| Debt / Assets | 10.02% |
| Net Debt / EBITDA | 1.13 |
| Interest Coverage | -80.94 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -4.65 |
Per-Share Data
| Revenue per share | 0.00 |
| Book Value per share | 1.39 |
| Cash per share | 1.49 |
| FCF per share | -1.02 |
| Tangible Book Value per share | 1.39 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 10 |
| Hold | 2 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 12 |
| Avg rating (1-5) | 0.83 |
Related companies: ALLO · AVIR · CAPR · EDIT · HUMA · IMMP · KYTX
Explore sector: Healthcare · Biotechnology
More sections of CABA: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks